Representative experience

We establish regulatory training programs to educate internal units of major medical device and combination product companies about adverse event reporting requirements and procedures.

We have assisted clients in responding to enforcement actions related to inadequate adverse event reporting and helped develop procedures to protect against future enforcement.

We regularly speak publicly on medical device reporting requirements and expectations.

Helped clients conduct retrospective reviews of their files to assess their obligations in submitting Medical Device Reports to the FDA and bring their reporting up to date.

Our lawyers have been named Best Lawyers of America, Washington D.C. Super Lawyers, The Legal 500 U.S. Healthcare: Life Sciences, and LMG Life Science’s Stars.

Our practice is ranked by Chambers USA as a top Healthcare: Pharmaceutical/Medical Products Regulatory practice.

Hogan Lovells Publications

U.S. Supreme Court rules judges must decide whether preemption applies, and clarifies when it does Pharmaceuticals and Biotechnology Alert

29 May 2019

Opinion highlights importance of a "clear" record at FDA

Hogan Lovells Publications

FDA issues final guidance for public warnings and notification of recalls Medical Device and Pharmaceutical and Biotechnology Alert

26 February 2019

Hogan Lovells Publications

MDR single report exemption and ASRs: Coming to an end for most reporters Medical Devices Alert

14 January 2019

The Medical Device Reporting (MDR) regulation provides a mechanism for the U.S. Food and Drug Administration (FDA or the Agency), as well as medical device manufacturers, to identify and...

Hogan Lovells Publications

Post-market medical devices, cybersecurity, and the U.S. FDA’s growing concerns

17 January 2018

From insulin pumps and pacemakers to defibrillators, medical devices increasingly rely on wireless and internet connectivity for efficient operations. Unfortunately, these interconnections...

Key contacts

Jodi Scott

Partner
Denver

Michael S. Heyl

Partner
Washington, D.C.

Edward C. Wilson, Jr.

Partner
Washington, D.C.

Elisabethann Wright

Partner
Brussels

Randy J. Prebula

Partner
Washington, D.C.

All related lawyers

We'd be happy to talk.

Please enter the valid data.

Your email

Please enter the valid data.

Type the text in the image here…

Please enter the valid data.

98SHc42/Fo0TuOypSOglKFwDaQYaUEgVFhKsAZCzoXY= {D4BD31A6-3DC4-40F3-A842-496ECD1CC33D} 98SHc42/Fo0TuOypSOglKFwDaQYaUEgVFhKsAZCzoXY= {7DE560D4-17FB-4249-BC32-46F2D20C1589} What would you like to discuss?

;

Adverse Event Reporting Vigilance Reporting

Representative experience

U.S. Supreme Court rules judges must decide whether preemption applies, and clarifies when it does Pharmaceuticals and Biotechnology Alert

FDA issues final guidance for public warnings and notification of recalls Medical Device and Pharmaceutical and Biotechnology Alert

MDR single report exemption and ASRs: Coming to an end for most reporters Medical Devices Alert

Post-market medical devices, cybersecurity, and the U.S. FDA’s growing concerns

Key contacts

Related practices